You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses

Article metrics

Article menu
XML
Immune cell therapies and immune cell engineering
Original research
Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses

 

Online download statistics by month:

Online download statistics by month: October 2020 to March 2024

AbstractFullPdf
Oct 202031931863
Nov 2020487484191
Dec 202017217277
Jan 202117017095
Feb 202111711761
Mar 202120020076
Apr 202111711753
May 202111911960
Jun 202111611659
Jul 2021989850
Aug 202113013079
Sep 202117417461
Oct 202113113188
Nov 202113113071
Dec 202114514591
Jan 202212013151
Feb 202210111567
Mar 202213815676
Apr 202211312346
May 202214315578
Jun 202213815161
Jul 2022808033
Aug 202211212770
Sep 202210811381
Oct 202210412690
Nov 202217017958
Dec 202210210241
Jan 2023989962
Feb 202312913254
Mar 2023125127105
Apr 202311511977
May 2023919658
Jun 2023909068
Jul 202311111181
Aug 202310410447
Sep 2023999956
Oct 202314815364
Nov 202313313653
Dec 202310611259
Jan 2024747543
Feb 202410110480
Mar 2024137137158
Total571658732992